Missing payday

24 March 2020 By Dasha Afanasieva Follow @dasha_reuters

Funds which bet on M&A deals have suffered hefty losses. Gyrating markets triggered risk limits, forcing some to sell out of deals that are very likely to go ahead, like luxury group LVMH’s $16 bln takeover of Tiffany. Arbitrageurs will lose much more than they stood to gain.

This content is for Subscribers only

Context News

Drugmaker AbbVie in June 2019 said it would buy Allergan in a deal that would give the Botox maker’s shareholders 0.866 AbbVie shares and $120.30 in cash for each share they owned. On Dec. 31, 2019 Allergan shares were trading at a 3% discount to the value of AbbVie’s offer. The spread widened to 5%, based on market prices on March 23.

French luxury group LVMH in November 2019 said it would acquire Tiffany & Co for $135 per share in cash, valuing the U.S.-listed jeweller’s equity at approximately $16.2 billion. Tiffany shares initially jumped to $133. On March 23 they were trading at $123, a discount of 10% to the offer price. The companies said on March 17 they expected to complete the deal in mid-2020.

The Frère and Desmarais families on March 11 said they intend to simplify their ownership structure of investment holding company Groupe Bruxelles Lambert. Minority shareholders in Pargesa, a Swiss-listed entity controlled by the families, were offered 0.93 GBL shares for each share they own.

On March 12 Pargesa shares were trading at a 1% discount to the implied value of the GBL offer. This widened to a 7% discount by March 20, before narrowing to 4% on March 23. The exchange offer is expected to last for a month until June 8 and the transaction is expected to close in the third quarter of 2020.

Context News

Email a friend

Please complete the form below.

Required fields *